Structure Therapeutics Cash Flow Statement (2022-2026) | GPCR

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -13.08M-13.95M-12.42M32.32M-17.98M-23.28M-23.86M55.70M-26.04M-26.03M-33.98M76.61M-46.83M-61.66M-65.71M177.78M-75.97M
Depreciation and Depletion (Quarter) 0.07M0.06M0.08M0.07M0.07M0.07M0.08M0.07M0.22M0.23M0.27M0.28M0.27M0.29M0.36M0.41M0.58M
Share-based Compensation (Quarter) 0.62M0.64M0.63M0.62M2.53M1.70M1.86M2.10M2.74M4.20M6.02M-11.26M5.92M7.51M7.50M8.07M11.64M
Deferred Taxes (Quarter) -0.01M-0.12M
Cash from Operations (Quarter) -13.52M-10.10M-10.48M-12.03M-20.31M-16.89M-20.56M-21.73M-34.08M-26.39M-19.70M-36.47M-52.23M-54.56M-51.00M-64.42M15.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.02M-0.01M0.32M0.01M
Depreciation & Amortization (CF) (Quarter) 0.07M0.06M0.08M0.07M0.07M0.07M0.08M0.07M0.22M0.23M0.27M0.28M0.27M0.29M0.36M0.41M0.58M
Change in Working Capital
Change in Account Payables (Quarter) -1.56M1.57M2.27M-0.12M-0.92M1.04M-2.38M1.40M1.82M-4.39M6.30M-0.42M0.69M0.28M8.81M-5.01M-4.97M
Change in Accured Expenses (Quarter) 0.54M2.49M-1.54M0.06M-0.56M3.48M6.09M3.15M-3.03M2.18M5.55M3.02M-0.99M3.60M3.88M15.02M-0.13M
Other Working Capital Changes (Quarter) -0.07M-0.10M-0.10M-0.08M-0.09M-0.10M-0.06M-0.07M-0.33M-0.45M-0.29M-0.52M-0.46M-0.63M-0.60M-0.60M0.21M
Investing Activities
Capital Expenditures (Quarter) 0.07M-0.05M0.07M-0.02M0.06M-0.08M0.33M-0.26M0.00M0.59M0.69M3.79M0.99M-0.44M0.95M2.12M1.18M
Change in Acquisitions & Divestments (Quarter) 2.00M10.50M29.40M19.60M141.08M-92.78M45.88M57.00M33.50M79.50M66.40M165.50M150.45M138.00M195.92M146.17M151.70M
Cash from Investing Activities (Quarter) -39.72M-16.07M-16.66M10.34M-49.02M-68.71M30.13M-180.74M1.42M-204.51M-189.04M33.23M34.03M48.94M-49.32M56.14M-496.95M
Financing Activities
Other financing activities (Quarter) 0.03M172.30M-172.09M172.09M127.70M0.76M0.48M0.40M0.22M0.96M0.04M-0.53M4.05M0.87M
Change in Capital Stock
Shares Issued (Quarter) 7.61M8.61M8.45M11.89M11.90M12.02M12.41M6.05M12.60M4.04M3.97M3.97M15.36M
Net Equity Issued and Repurchased (Quarter) 57.10M
Misc.
Cash from Financing Activities (Quarter) -1.45M31.04M-0.26M-0.32M169.73M-0.30M0.47M281.63M0.70M514.70M-0.76M0.61M0.81M0.52M56.20M704.99M-1.74M
Change in Cash (Quarter) -54.68M4.87M-27.40M-2.00M100.40M-85.90M10.04M79.16M-31.96M283.80M-209.50M-2.62M-17.39M-5.10M-44.11M696.71M-483.45M
Free Cash Flow (Quarter) -13.58M-10.04M-10.55M-12.00M-20.37M-16.81M-20.89M-21.46M-34.08M-26.98M-20.38M-40.25M-53.22M-54.11M-51.94M-66.54M14.05M
Net Cash Flow (Quarter) -54.68M4.87M-27.40M-2.00M100.40M-85.90M10.04M79.16M-31.96M283.80M-209.50M-2.62M-17.39M-5.10M-44.11M696.71M-483.45M